Sep 4 2012
GE
Healthcare, the healthcare business of GE (NYSE: GE), today
introduced KUBioTM, an innovative off-the-shelf, modular
factory designed to save manufacturers of biopharmaceuticals both time
and money. KUBio's pre-made modules, which are assembled at a customer's
chosen site to make a fully functional ready-to-run bioprocessing
facility, are significantly faster to install than constructing a
traditional factory. The modules are equipped with GE Healthcare's
world-class technologies for the start-to-finish manufacture of
biopharmaceuticals.
Worldwide demand for biopharmaceuticals - such as antibodies for the
treatment of cancer and rheumatoid arthritis, as well as the new
generation of innovative vaccines - is increasing dramatically, driven
by the global ageing population, rising obesity levels and the global
effort to reduce the incidence of vaccine preventable diseases. KUBio
will help manufacturers to respond to local healthcare needs and bring
these potentially life-saving treatments to market more quickly.
KUBio is a fully functional off-the-shelf bioprocessing facility
specifically designed to meet cGMP requirements while optimizing
manufacturing flexibility and productivity. The 1200m2 facility
is pre-fabricated and delivered with a complete ready-to-use production
line, based on GE Healthcare's Ready-to-ProcessTM single-use
technologies. With a total planning, delivery and construction time of
14-18 months, compared to the traditional 24 -36 months, both
time-to-market and level of capital investment are significantly
reduced. The first modular facilities to be introduced will be
configured for the manufacture of monoclonal antibodies. GE Healthcare
also plans to introduce modules for the manufacture of other
biopharmaceuticals.
"KUBio is a totally new approach to the manufacture of
biopharmaceuticals, bringing our customers a greatly simplified way to
build their production capacity," said Olivier Loeillot, General Manager
of Enterprise Solutions, GE Healthcare Life Sciences. "With KUBio our
customers will be able to cut months off the typical construction time,
and greatly streamline the whole construction process. We're already
seeing interest from a wide range of customers, from governments wanting
to develop in-country manufacturing capability right through to
pharmaceutical companies wanting to expand production capacity in new
locations. KUBio is an industry game-changer that will help them do just
that."
The introduction of KUBio expands GE Healthcare's broad offering of
world-class tools, technologies and services for the biopharmaceutical
manufacturing industry, allowing customers to benefit from a wide range
of solutions that can be tailored to meet specific needs, from pilot to
commercial scale. GE Healthcare's start-to-finish technologies and
services include Fast Trak training, PAA cell culture media,
ReadyToProcess single use technologies, specialist purification media
and Xcellerex biomanufacturing systems. KUBio aligns with GE's
healthymagination initiative which focuses on reducing cost, increasing
access and improving quality in healthcare.